1,508 results on '"Becker, Jürgen C."'
Search Results
2. Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates
3. Correction: Mesenchymal–epithelial transition in lymph node metastases of oral squamous cell carcinoma is accompanied by ZEB1 expression
4. Comparative efficacy of combined CTLA-4 and PD-1 blockade vs. PD-1 monotherapy in metastatic melanoma: a real-world study
5. Early versus late response to PD-1-based immunotherapy in metastatic melanoma
6. The effect of GP-2250 on cultured virus-negative Merkel cell carcinoma cells: preliminary results
7. The HDAC inhibitor domatinostat induces type I interferon α in Merkel cell carcinoma by HES1 repression
8. Short- and long-term immunosuppressive effects of melanoma influence the prognostic value of the sentinel lymph node status
9. Wnt/β-Catenin–Activated Nonpilomatrical Carcinoma of the Skin: A Case Series
10. The RANKL inhibitor denosumab in combination with dual checkpoint inhibition is associated with increased CXCL-13 serum concentrations
11. Mesenchymal–epithelial transition in lymph node metastases of oral squamous cell carcinoma is accompanied by ZEB1 expression
12. Undifferentiated pleomorphic sarcoma of the breast with neoplastic fever: case report and genomic characterization
13. Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma – analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM
14. Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial
15. Identification of Epigenetically Regulated Genes Distinguishing Intracranial from Extracranial Melanoma Metastases
16. Characterisation and outcome of RAC1 mutated melanoma
17. Merkel cell carcinoma of the anorectum: a case report and review of the literature
18. Cutaneous Aspects of Leukemia
19. Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma
20. German S3 guideline “actinic keratosis and cutaneous squamous cell carcinoma” – Long version of the update 2023
21. Incidence and Relative Survival of Patients with Merkel Cell Carcinoma in North Rhine-Westphalia, Germany, 2008–2021
22. Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases
23. A Prospective Study Investigating Immune Checkpoint Molecule and CD39 Expression on Peripheral Blood Cells for the Prognostication of COVID-19 Severity and Mortality
24. Current Progress in Vaccines against Merkel Cell Carcinoma: A Narrative Review and Update
25. S1‐Leitlinie Talgdrüsenkarzinom
26. Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial
27. Persister state-directed transitioning and vulnerability in melanoma
28. Analyses of combined Merkel cell carcinomas with neuroblastic components suggests that loss of T antigen expression in Merkel cell carcinoma may result in cell cycle arrest and neuroblastic transdifferentiation.
29. Single-cell RNA and T-cell receptor sequencing unveil mycosis fungoides heterogeneity and a possible gene signature.
30. Introducing MCC-PS: a novel prognostic score for Merkel cell carcinoma.
31. DNA-methylation patterns imply a common cellular origin of virus- and UV-associated Merkel cell carcinoma
32. Merkel Cell Carcinoma
33. Classical and Variant Merkel Cell Carcinoma Cell Lines Display Different Degrees of Neuroendocrine Differentiation and Epithelial-Mesenchymal Transition
34. The HDAC Inhibitor Domatinostat Promotes Cell-Cycle Arrest, Induces Apoptosis, and Increases Immunogenicity of Merkel Cell Carcinoma Cells
35. Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma
36. BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes
37. Merkel-Zell-Karzinom
38. T antigen–specific CD8+ T cells associate with PD-1 blockade response in virus-positive Merkel cell carcinoma
39. Other Cutaneous Tumors: Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma, and Cutaneous Sarcomas
40. T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma
41. Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53
42. Merkel cell polyomavirus pan‐T antigen knockdown reduces cancer cell stemness and promotes neural differentiation independent of RB1.
43. S1‐Leitlinie Talgdrüsenkarzinom: S1‐Guideline Sebaceous Carcinoma.
44. S1‐Guideline Sebaceous Carcinoma.
45. MCPyV Large T Antigen-Induced Atonal Homolog 1 Is a Lineage-Dependency Oncogene in Merkel Cell Carcinoma
46. T antigen–specific CD8+ T cells associate with PD-1 blockade response in virus-positive Merkel cell carcinoma
47. S3‐Leitlinie “Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Update 2023, Teil 2: Epidemiologie und Ätiologie, Diagnostik, Therapie des invasiven Plattenepithelkarzinoms der Haut, Nachsorge und Prävention
48. UV-type specific alteration of miRNA expression and its association with tumor progression and metastasis in SCC cell lines
49. Conversion of Sox2-dependent Merkel cell carcinoma to a differentiated neuron-like phenotype by T antigen inhibition
50. Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.